TY - JOUR PY - 2011// TI - Paracetamol orodispersible tablets: a risk for severe poisoning in children? JO - European journal of clinical pharmacology A1 - Ceschi, Alessandro A1 - Hofer, Katharina E. A1 - Rauber-Lüthy, Christine A1 - Kupferschmidt, Hugo SP - 97 EP - 99 VL - 67 IS - 1 N2 - PURPOSE: Childhood paracetamol (acetaminophen) ingestion with subsequent risk of hepatotoxicity is a major medical problem. The aim of this study was to investigate the risk of high-dose ingestion of orodispersible, fast-disintegrating paracetamol tablets in children. METHODS: A retrospective single-center case study of all accidental selfadministrations of solid or orodispersible 500-mg paracetamol tablets occurring in children ≤ 6 years, reported to the Swiss Toxicological Information Centre between June 2003 and August 2009. RESULTS: We found 187 cases with ingestion of solid 500-mg paracetamol tablets and 16 cases with ingestion of orodispersible 500-mg tablets. The mean ingested dose in the orodispersible-tablet group was 59% higher than in the solid-tablet group (p = 0.085). Administration of activated charcoal and/or N-acetylcysteine because of ingestion of a potentially hepatotoxic paracetamol dose ( ≥ 150 mg/kg body weight) was recommended in 32 patients (17.1%) in the solid-tablet group and in five (31%) in the orodispersible-tablet group. CONCLUSIONS: Orodispersible paracetamol formulations may represent an important risk factor for severe paracetamol poisoning in children. Over-the-counter availability may contribute to increasing the use of this galenic formulation and eventually the number of poisonings in children.
Language: en
LA - en SN - 0031-6970 UR - http://dx.doi.org/10.1007/s00228-010-0943-x ID - ref1 ER -